Literature DB >> 8887302

Erythropoietin in chronic renal failure.

F Valderrábano1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8887302     DOI： 10.1038/ki.1996.452

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  9 in total

1.  Individualized drug dosing using RBF-Galerkin method: Case of anemia management in chronic kidney disease.

Authors:  Hossein Mirinejad; Adam E Gaweda; Michael E Brier; Jacek M Zurada; Tamer Inanc
Journal:  Comput Methods Programs Biomed       Date:  2017-06-23       Impact factor: 5.428

2.  Association of Erythropoietin Dose and Route of Administration with Clinical Outcomes for Patients on Hemodialysis in the United States.

Authors:  Daniel G Wright; Elizabeth C Wright; Andrew S Narva; Constance T Noguchi; Paul W Eggers
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-10       Impact factor: 8.237

3.  Mimicry of erythropoietin by a nonpeptide molecule.

Authors:  S A Qureshi; R M Kim; Z Konteatis; D E Biazzo; H Motamedi; R Rodrigues; J A Boice; J R Calaycay; M A Bednarek; P Griffin; Y D Gao; K Chapman; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 4.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

5.  Iron inhibits respiratory burst of peritoneal phagocytes in vitro.

Authors:  Kamil Gotfryd; Aleksandra Jurek; Piotr Kubit; Andrzej Klein; Bohdan Turyna
Journal:  ISRN Urol       Date:  2011-12-08

6.  Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.

Authors:  David Wayne Johnson; Carmel Mary Hawley; Brenda Rosser; Elaine Beller; Charles Thompson; Robert G Fassett; Paolo Ferrari; Stephen MacDonald; Eugenie Pedagogos; Alan Cass
Journal:  BMC Nephrol       Date:  2008-08-01       Impact factor: 2.388

7.  Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).

Authors:  Katherine A Barraclough; Euan Noble; Diana Leary; Fiona Brown; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; David W Mudge; Carolyn L van Eps; Joanna M Sturtevant; David W Johnson
Journal:  BMC Nephrol       Date:  2009-07-28       Impact factor: 2.388

8.  An easy-to-operate web-based calculator for predicting the progression of chronic kidney disease.

Authors:  Qian Xu; Yunyun Wang; Yiqun Fang; Shanshan Feng; Cuiyun Chen; Yanxia Jiang
Journal:  J Transl Med       Date:  2021-07-03       Impact factor: 5.531

9.  Quality of life in dialysis patients from the United Arab Emirates.

Authors:  Abdelbasit M Ayoub; Kamal H Hijjazi
Journal:  J Family Community Med       Date:  2013-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.